ReviewThe journal of nutrition, health & aging2009

The validity of biomarkers as surrogate endpoints in Alzheimer's disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES).

C C Gispen-de Wied et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.